Kerala Ayurveda has informed that pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, November 12, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2026. Further, pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, and Company’s Code of Conduct for Regulating, Monitoring, Preventing and Reporting of Trading in Securities by Insiders and Designated Persons and Immediate Relatives of Designated Persons, the trading window for dealing in the securities of the Company has been closed from September 30, 2026, for the designated persons and will be opened 48 hours after announcement of unaudited financial results for the quarter and half year ended on September 30, 2026.
The above information is a part of company’s filings submitted to BSE.